Stanley Capital

The firm has not publicly disclosed its full investment committee roster, though founder Simon Cottle leads the overall strategy and team buildout. The website describes a flat structure organized around specific competencies rather than seniority, which suggests a collaborative approval process rather than a single key-person dependency.

Stanley Capital states it uses proprietary research to find value locked up in growth businesses, particularly in healthcare and resource efficiency mid-market companies across Europe. The firm does not disclose specific sourcing partnerships or exclusive deal pipelines beyond this internally driven model.

Stanley Capital operates as a direct private equity firm executing buyouts and growth investments. It has not disclosed any fund-of-funds activity or LP commitments to third-party managers, maintaining a pure direct investment posture on mid-market platform companies.

The firm targets companies with enterprise values between $250 million and $2.5 billion, consistent with mid-market buyout and expansion-stage investing. While its strategy menu mentions early-stage exposures, its public-facing posture emphasizes mature growth businesses in need of operational transformation.

Stanley Capital does not publish an explicit exclusion list, but its public materials name only healthcare and resource efficiency as active focus areas. Sectors such as consumer goods, financial services, media, or real estate are absent from all disclosed strategy documentation, implying a deliberate narrow mandate.